manualshive.com logo in svg
background image

20 

 

Table 5. Prevention and management of potential complications 

Complication

 

Prevention and management

 

Thrombus formation within the heart,  circuit or system components  Assess thrombi with TEE for stability; and remove during 

surgery or address with appropriate anticoagulation.  Delay 
weaning, if  necessary, until resolved. 
Avoid conditions which can cause suction or line  chatter. Avoid 
flexing the tubing, particularly near  the connectors, which can 
dislodge fibrin or deposits. 

Hemolysis 

Troubleshoot to identify cause: cannula position,  cannula 
selection, CVVH, oxygenator, kinked tubing, another 
device, high RPM/flow.  Check that pump is mounted 
properly. Consider pump change if suspect as a final 
option. 

Pump not inserted correctly 

Mount the pump correctly. Change pump if  incorrect 
mount is accompanied by platelet consumption &/or 
hemolysis. 

Console or motor malfunction 

Switch pump to backup console and  motor. Document, 
replace, and report. 

Decannulation 

Prevent by securing the cannulas to the tissue at  multiple 
sites following cannulation. Minimize  postoperative patient 
and circuit movement.  Use extreme care when moving the 
patient. 

Air entrainment and embolism 

Immediately clamp pump outlet tubing. Stop pump. 
Depending on circumstances and anticoagulation, consider 
splicing in a connector, deairing, and/or pump exchange. 

Alarms/Alerts and Troubleshooting 

For information on alarms and alerts, refer to the CentriMag Circulatory Support System Operation Manual. 

Weaning and Explantation

 

Recovery sufficient for removal from CentriMag system support will depend on specific patient hemodynamic status. Depending on 
the extent of myocardial injury:

 

 

Patients may recover sufficiently to be weaned within 48 to 72 hours. 

 

Patients may require support for multiple weeks. 

 

Patients may not recover sufficiently to be weaned from support and will required long-term support with an implantable LVAD 
or heart transplant. 

Improvement in ventricular function is usually first noted with increased contractility and ventricular ejection apparent on the 
arterial pressure waveform, decreased flow required to maintain patient hemodynamics, and a decreased dependence on inotropic 
support. Initial assessments of ventricular function should be made without increasing inotropic support, IABP support, or without 
volume loading of the ventricles. Echocardiography is useful to assess improvement in ventricular size, wall motion and ejection 
fraction. When possible, a pulmonary artery catheter provides useful information on recovery. Recovery is based on the patient’s 
ability to maintain hemodynamic status, perfusion, and end organ function during extended period of low CentriMag system flow 
without additional pharmacological or mechanical support. 

 

CAUTION: There is a risk of thrombosis if the pump flow is reduced without adequate anticoagulation. Before you reduce the 
pump speed, allow time for adequate anticoagulation circulation. 

CAUTION: If the drainage or return cannula is placed directly in the heart (left or right atria or ventricles), then the removal 
of blood from the heart will unload the heart and reduce the amount of blood flowing through the ventricular outflow 
(pulmonary or aortic) valves. 

A trial period of CentriMag system weaning over at least three hours may be attempted after the following criteria are met: 

 

Hemodynamic evidence of ventricular function improvement based on increased cardiac output 

 

Increase in mean arterial blood pressure 

 

Documented pressure, echocardiographic evidence, or TEE evidence of ventricular ejection with little or no inotropic support 

Initial attempts to wean should be short in duration with an appropriate increase in anticoagulation and gradual reduction in pump 
flow to 1.5 to 2.0 liters per minute. If the ventricles become visibly dilated on TEE, mixed venous oxygen saturation is compromised, 
or the patient's hemodynamic parameters deteriorate, the weaning attempt should be discontinued. 
Once weaning is successful, expect increased pharmacological support to be required. 

WARNING: After you wean the patient from support, closely monitor their hemodynamics for deterioration, as this may 
require emergent re-initiation of support. 

 

Weaning Protocol 

The most appropriate timing for weaning CentriMag system support has not been determined and there are no specific criteria. Key 
parameters to assess for weaning are ventricular contractility and ejection. As the heart recovers function, the pulse pressure on the 

Содержание CentriMag

Страница 1: ...ENTRIMAG CIRCULATORY SUPPORT SYSTEM Abbott Medical Clinical Technical Support Phone number s United States Emergency HeartLine Support USA Tel 1 800 456 1477 Abbott Medical Main Switchboard Tel 1 925...

Страница 2: ...3 Indicates a trademark of the Abbott group of companies Indicates a third party trademark which is property of its respective owner Pat http www abbott com patents 2019 Abbott All Rights Reserved...

Страница 3: ...14 Intraoperative Device Management 15 Guidelines to Prevent Air Entrainment when Initiating Support 15 Patient Care and Management 15 Guidelines to Prevent Air Entrainment during Support 16 CentriMag...

Страница 4: ...5 Safety and Effectiveness and Results 27 Device Malfunctions and Failures 30 Clinical Study Safety and Effectiveness Conclusions 33...

Страница 5: ...ce The CentriMag Circulatory Support System is indicated for use as a right ventricular assist device Humanitarian Device The system when used as a right ventricular assist device is also authorized b...

Страница 6: ...right ventricular assist device TEE transesophageal echocardiography TEG thromboelastography Description The CentriMag system is designed to provide a versatile and effective means for implementing me...

Страница 7: ...t be set high enough to overcome native cardiac pressure in order to prevent retrograde flow Increasing the RPM will increase the flow of blood through the pump CAUTION If an increase in set speed doe...

Страница 8: ...15 20 mmHg are suggestive of right ventricular dysfunction Such a condition is often associated with a decrease in right ventricular contractility and tricuspid insufficiency If adequate LVAD flow can...

Страница 9: ...plies that may be used for this technique 4 CentriMag pumps Drainage cannulas Return cannulas 2nd Generation CentriMag console with motor and flow probe connected Standard 3 8 ID x 3 32 wall tubing Tw...

Страница 10: ...echnique should be performed using aseptic techniques To prime the pump 1 Fill a large sterile basin with three liters of a warm balanced electrolyte solution 2 Slowly submerge one end of the drainage...

Страница 11: ...ailable venous and arterial cannula may be used at the preference of the clinician For central cannulation it is advisable to use cannulas that are wire reinforced to resist kinking The drainage cannu...

Страница 12: ...clamps are removed before the speed is set higher than 1000 RPMs there is a risk of retrograde flow NOTE If other manufacturers cannulas are used follow standard surgical techniques applicable to thos...

Страница 13: ...tions above for left and right sided support See options above for left and right sided support Two cannulation approaches are shown in the figures below The left ventricle is drained via the left ven...

Страница 14: ...E hemodynamic monitoring palpation and direct visualization of the heart will help to determine the volume of blood available for the circuit and the optimal level of flow After the chest is closed th...

Страница 15: ...econds allowing the patient s vascular system to adjust between each RPM change The pump set speed should be gradually increased to the desired flow If flow drops or tubing chatter is observed the set...

Страница 16: ...during insertion line chatter ramping of the flows or flow below the minimum alert Place a stopcock on the open ports of the central line to avoid air being entrained CAUTION Never leave any ports op...

Страница 17: ...Wound sites should be carefully inspected for signs of tissue breakdown or excessive drainage Undue pressure or torque to the surgical site should be avoided in order to minimize trauma with special c...

Страница 18: ...atient during transport Prior to shutting off the power supply and removal of the patient from the transport vehicle briefly unplug the console s power cord to confirm adequate battery charge and cons...

Страница 19: ...d a decreased dependence on inotropic support Initial assessments of ventricular function should be made without increasing inotropic support IABP support or without volume loading of the ventricles E...

Страница 20: ...5 The new tubing connectors are attached using a wet wet connection while taking care to eliminate air at the junction as well as in the circuit Secure these new connections with bands 6 Ensure that...

Страница 21: ...ents suffering from post cardiotomy cardiogenic shock who were unable to be separated from CPB prior to leaving the operating room Clinical Inclusion Criteria Enrollment in the studies was limited to...

Страница 22: ...pport Not applied to this study All possible measures have been attempted to correct low arterial pH arterial blood gas abnormalities electrolytes hypovolemia hypervolemia inadequate cardiac rate dysr...

Страница 23: ...entriMag system removal Adverse events and complications were recorded throughout the duration of CentriMag system support through device removal and until the patient was discharged from the hospital...

Страница 24: ...1 12 Patients N 32 26 12 25 Sex Male 24 75 15 58 8 67 20 80 Female 8 25 11 42 4 33 5 20 Race White 24 75 4 13 4 13 N A13 N A13 19 76 4 16 2 8 African American Other Age mean years SD 58 13 8 59 11 6 5...

Страница 25: ...seline Laboratory Values FTW from CPB G030052 S21 Variable N Mean SD Median Min Max Blood Urea Nitrogen mg dl 32 39 1 21 3 32 12 94 Creatinine mg dl 32 1 8 0 8 1 6 0 9 4 Total Bilirubin mg dl 31 1 8 1...

Страница 26: ...ut not identical across the studies so direct comparisons are not possible However the table shows that general trends in types and incidence of adverse events were similar across all four studies Tab...

Страница 27: ...otension 1 1 3 5 5 19 2 2 17 0 0 0 8 8 8 Hepatic Dysfunction 1 1 3 8 7 27 3 2 17 0 0 0 12 10 11 Renal Failure Dysfunction 8 8 25 3 3 12 1 1 8 12 12 48 24 24 25 Neurologic Dysfunction 0 0 0 8 8 31 2 2...

Страница 28: ...4 4 Other 1219 9 28 0 0 0 0 0 0 2120 10 40 33 19 20 19 Right arm compartment syndrome bronchorrhea and desaturation cardiogenic shock with suspected platelet dysfunction tear in ventricular tissue nea...

Страница 29: ...valuate the safety of the device These data were obtained by analyzing adverse events associated with marketed CentriMag systems which were reported to Abbott Medical between June 1 2014 and June 30 2...

Страница 30: ...he tables below Table 15 CentriMag Effectiveness in FTW Subjects from CPB Pivotal Study G030052 S21 Survival and Primary Endpoint Clinical Study N Survival to 30 Days Post device Survival To Discharge...

Страница 31: ...y Endpoint Clinical Study N Survival to 30 Days Post device Survival to Discharge Primary Endpoint Success Cardiogenic Shock Trial G030052 22 26 11 26 42 Not Defined RVAS Trial G040029 23 12 7 12 58 N...

Страница 32: ...ing acute myocardial infarction or post cardiotomy failure to wean from cardiopulmonary bypass and in patients with acute right ventricular failure from any cause In all studies the adverse event rate...

Отзывы: